Tayyaba Hasan

Last updated
Tayyaba Hasan
Alma mater University of Karachi
University of Islamabad
University of Arkansas
Known for Visudyne
Scientific career
Fields Dermatology
Photodynamic therapy
Institutions University of Pennsylvania
Harvard Medical School
Massachusetts General Hospital
Website hasanlab.mgh.harvard.edu/about-us/tayyaba-hasan

Tayyaba Hasan is a Professor of Dermatology at the Wellman Center for Photomedicine at Harvard Medical School. She is one of the inventors of Visudyne, a Food and Drug Administration approved treatment for age-related macular degeneration. She received the 2018 SPIE Britton Chance Biomedical Optics Award.

Contents

Early life and education

Hasan completed her bachelor's degree in chemistry at the University of Karachi in 1966. [1] She earned her master's degree in 1968, specialising in organic chemistry. [1] In 1970 Hasan gained a second master's degree from the University of Islamabad. [1] She won the National Merit Scholarship from the Punjab Education Foundation. She moved to the University of Arkansas for her postgraduate research, earning a PhD in organic chemistry in 1980. [1] [2] She was elected to Sigma Xi. [3]

Research

After completing her PhD, Hasan joined the University of Pennsylvania as a postdoctoral research associate. She joined Harvard Medical School in 1982. [4] Hasan worked with Alan Oseroff on antibody conjugate photosensitization of cells for receptor-based photolysis. [5] She showed it was possible to target sub-cellular structures by photosensitisation. [5] [6] Hasan uses photodynamic therapy to diagnose and treat disease. [7] She has trained dermatologists, ophthalmologists, urologists, gynaecologists and orthopaedic surgeons. [5]

She demonstrated that benzoporphryin derivatives could be used to eliminate of subretinal vessels. [5] She went on to discover visudyne with Ursula Schmidt. [5] Visudyne is one of over twenty patents held by Hasan. [5] She was appointed to professor of dermatology in 2009. [8] Her recent work considers ways to target glioma treatment and ovarian cancer. [5] In 2011 she was the founding director of the Office for Research Career Development at Massachusetts General Hospital. [9] She is targeting diseases such as leishmaniasis, mycobacterium tuberculosis and methicillin-resistant Staphylococcus aureus. [9] Hasan's lab focusses on the photophysical and biological mechanisms of photodynamic therapy. [10] She leads a National Cancer Institute funded project focussed on image-guided therapy for pancreatic and skin cancers. [11] [12] These include singlet oxygen formation, cytokine secretion. [10]

The Hasan Lab run several separate research projects: [13]

Hasan has served on the executive boards of several learned societies, including acting as President of the International Photodynamic Association, Vice President of Science for the Pan American PDT Association and President of the American Society for Photobiology (2010 - 2012). [18] She contributed to the 2014 book Photodynamic Therapy: From Theory to Application. [4] She serves on the advisory board of Polythea. [19]

Awards

Related Research Articles

<span class="mw-page-title-main">Photodynamic therapy</span> Form of phototherapy

Photodynamic therapy (PDT) is a form of phototherapy involving light and a photosensitizing chemical substance, used in conjunction with molecular oxygen to elicit cell death (phototoxicity).

Naomi J. Halas is the Stanley C. Moore Professor in Electrical and Computer Engineering, and professor of biomedical engineering, chemistry and physics at Rice University. She is also the founding director of Rice University Laboratory for Nanophotonics, and the Smalley-Curl Institute. She invented the first nanoparticle with tunable plasmonic resonances, which are controlled by their shape and structure, and has won numerous awards for her pioneering work in the field of nanophotonics and plasmonics. She was also part of a team that developed the first dark pulse soliton in 1987 while working for IBM.

SPIE is an international not-for-profit professional society for optics and photonics technology, founded in 1955. It organizes technical conferences, trade exhibitions, and continuing education programs for researchers and developers in the light-based fields of physics, including: optics, photonics, and imaging engineering. The society publishes peer-reviewed scientific journals, conference proceedings, monographs, tutorial texts, field guides, and reference volumes in print and online. SPIE is especially well-known for Photonics West, one of the laser and photonics industry's largest combined conferences and tradeshows which is held annually in San Francisco. SPIE also participates as partners in leading educational initiatives, and in 2020, for example, provided more than $5.8 million in support of optics education and outreach programs around the world.

<span class="mw-page-title-main">Bruce J. Tromberg</span> American chemist

Bruce J. Tromberg is an American photochemist and a leading researcher in the field of biophotonics. He is the director of the National Institute of Biomedical Imaging and Bioengineering (NIBIB) within the National Institutes of Health (NIH). Before joining NIH, he was Professor of Biomedical Engineering at The Henry Samueli School of Engineering and of Surgery at the School of Medicine, University of California, Irvine. He was the principal investigator of the Laser Microbeam and Medical Program (LAMMP), and the Director of the Beckman Laser Institute and Medical Clinic at Irvine. He was a co-leader of the Onco-imaging and Biotechnology Program of the NCI Chao Family Comprehensive Cancer Center at Irvine.

Photoimmunotherapy (PIT) is an oncological treatment that combines photodynamic therapy of tumor with immunotherapy treatment. Combining photodynamic therapy with immunotherapy enhances the immunostimulating response and has synergistic effects for metastatic cancer treatment.

Joan Whitten Miller is a Canadian-American ophthalmologist and scientist who has made notable contributions to the treatment and understanding of eye disorders. She is credited for developing photodynamic therapy (PDT) with verteporfin (Visudyne), the first pharmacologic therapy for retinal disease. She also co-discovered the role of vascular endothelial growth factor (VEGF) in eye disease and demonstrated the therapeutic potential of VEGF inhibitors, forming the scientific basis of anti-VEGF therapy for age-related macular degeneration (AMD), diabetic retinopathy, and related conditions.

Julia Levy is a Canadian microbiologist, immunologist, educator and entrepreneur.

Samuel Achilefu is a Nigerian-born scientist and medical researcher who has pioneered both fundamental and applied research in science, engineering, and medicine. Dr. Samuel Achilefu is Professor and Chair of the Department of Biomedical Engineering at the University of Texas Southwestern Medical Center, where he holds the Lyda Hill Distinguished University Chair in Biomedical Engineering. He is also Professor of Radiology and a member of the Simmons Comprehensive Cancer Center. Before joining UT Southwestern, he was the Michel M. Ter-Pogossian Professor of Radiology and Vice Chair for Innovation and Entrepreneurship at the Mallinckrodt Institute of Radiology, Washington University School of Medicine. He held joint appointments as a professor of medicine, biochemistry and molecular biophysics, and biomedical engineering. He also served as the Director of the Washington University Molecular Imaging Center and the privately funded Theranostic Innovation Program and was co-director of the Center for Multiple Myeloma Nanotherapy and co-Leader of the Oncologic Imaging Program of the Alvin J. Siteman Cancer Center at Washington University.

Maryellen L. Giger, is an American physicist and radiologist who has made significant contributions to the field of medical imaging.

Elizabeth M. C. Hillman is a British-born academic who is Professor of Biomedical Engineering and Radiology at Columbia University. She was awarded the 2011 Adolph Lomb Medal from The Optical Society and the 2018 SPIE Biophotonics Technology Innovator Award.

Eva Ramón Gallegos is a Mexican scientist, professor and researcher at the Escuela Nacional de Ciencias Biológicas of the Instituto Politécnico Nacional. Her field of specialty is in biomedical sciences and nanobiotechnology. Her main line of research is the search for non-invasive treatments for the eradication of the uterine cervical cancer produced by the human papilloma virus (HPV), using photodynamic therapies.

<span class="mw-page-title-main">Georgia Tourassi</span> Physicist

Georgia "Gina" D. Tourassi is the Director of the Oak Ridge National Laboratory health data sciences institute and adjunct Professor of radiology at Duke University. She works on biomedical informatics, computer-aided diagnosis and artificial intelligence (AI) in health care.

<span class="mw-page-title-main">Anita Mahadevan-Jansen</span> Biomedical engineer

Anita Mahadevan-Jansen is a Professor of Biomedical Engineering and holds the Orrin H. Ingram Chair in Biomedical Engineering at Vanderbilt University. Her research considers the development of optical techniques for clinical diagnosis and surgical guidance, particularly using Raman and fluorescence spectroscopy. She serves on the Board of Directors of SPIE, and is a Fellow of SPIE, The Optical Society, Society for Applied Spectroscopy, and the American Society for Lasers in Medicine and Surgery. She was elected to serve as the 2020 Vice President of SPIE. With her election, Mahadevan-Jansen joined the SPIE presidential chain and served as President-Elect in 2021 and the Society's President in 2022.

Kristen Carlson Maitland is an associate professor at Texas A&M University. She develops optical instrumentation for the detection and diagnosis of diseases, including infection and cancer. She has served on the Board of Directors of SPIE.

Nirmala "Nimmi" Ramanujam is the Robert W. Carr Professor of Biomedical Engineering, and a faculty member in the Global Health Institute and the Department of Pharmacology & Cell Biology at Duke University. She is the director of the Center of Global Women's Health Technologies (GWHT) and founder of Zenalux Biomedical Inc. and Calla Health. Ramanujam has spent the last two decades developing precision diagnostics and more recently precision therapeutics for breast and cervical cancer, with a focus on addressing global health disparities. She has more than 20 patents and over 150 publications for screening, diagnostic, and surgical applications, and has raised over $30M of funding to pursue these innovations through a variety of funding mechanisms, including NIH R01s and R21s, NIH Bioengineering Partnerships, NCI Academic Industry Partnerships, NIH Small Business grants and USAID funding. As the founding director of the Center for Global Women's Health Technologies at Duke University, she has developed a consortium of over 50+ partners including international academic institutions and hospitals, non-governmental organizations, ministries of health, and commercial partners; this consortium is working to ensure that the technologies developed at the center are adopted by cancer control programs in geographically and economically diverse healthcare settings.

<span class="mw-page-title-main">Christine P. Hendon</span> American electrical engineer and computer scientist

Christine P. Hendon is an electrical engineer and computer scientist and an associate professor in the Department of Electrical Engineering at Columbia University in New York City. Hendon is a pioneer in medical imaging. She develops biomedical optics technologies, using optical coherence tomography and near infrared spectroscopy systems, that enable physicians to perform guided interventional procedures and allow for structure-function dissection of human tissues and organs. Her advances in imaging technologies have led to improved diagnostic abilities and treatments for cardiac arrhythmias as well as breast cancer and preterm birth. She has been recognized for her development of optical imaging catheters for cardiac wall imaging by Forbes 30 under 30, the MIT Technology Review’s 35 Innovators Under 35, and by President Obama with the Presidential Early Career Awards in 2017.

Audrey K. Ellerbee Bowden is an American engineer and Dorothy J. Wingfield Phillips Chancellor's Faculty Fellow at Vanderbilt University, as well as an Associate Professor of Biomedical Engineering and Electrical Engineering. She is a Fellow of Optica, the American Institute for Medical and Biological Engineering and the International Society for Optics and Photonics (SPIE).

Irene Georgakoudi is a Greek biophysicist and Professor of Biomedical Engineering at Tufts University, where her work focuses on developing non-invasive medical imaging techniques based on optical spectroscopy for applications in medical diagnostics and therapeutics.

Jennifer Kehlet Barton is an American biomedical engineer who is Director of the BIO5 Institute at the University of Arizona. Barton develops optical techniques for the detection and treatment of cancer.

Katarina Svanberg is a Swedish physician who is Professor and Chief Consultant of Oncology at the Skåne University Hospital. Her research considers the use of fluorescence-based tumour imaging and photodynamic therapy. She served as President of SPIE in 2011 and was awarded the SPIE Gold Medal in 2017.

References

  1. 1 2 3 4 "Tayyaba Hasan on developments in photodynamic therapy". spie.org. Retrieved 2018-08-20.
  2. ↑ "Fayetteville Northwest Arkansas Times Archives, Apr 11, 1979, p. 11". NewspaperArchive.com. 1979-04-11. Retrieved 2018-08-20.
  3. ↑ "Sigma Xi member directory". Sigma Xi. Retrieved 2018-08-19.
  4. 1 2 Abdel-Kader, Mahmoud H. (2014-01-09). Photodynamic Therapy: From Theory to Application. Springer Science & Business Media. ISBN   9783642396298.
  5. 1 2 3 4 5 6 7 Pogue, Brian W.; Wagnières, Georges; Lilge, Lothar D. (September 2010). "Special Section Guest Editorial: Pioneers in Biomedical Optics: Special Section Honoring Professor Tayyaba Hasan". Journal of Biomedical Optics. 15 (5): 051601–051601–2. Bibcode:2010JBO....15e1601P. doi: 10.1117/1.3492580 . ISSN   1083-3668. PMID   21054075.
  6. ↑ Shea, C. R.; Chen, N.; Wimberly, J.; Hasan, T. (1989-07-15). "Rhodamine dyes as potential agents for photochemotherapy of cancer in human bladder carcinoma cells". Cancer Research. 49 (14): 3961–3965. ISSN   0008-5472. PMID   2736534.
  7. ↑ "Tayyaba Hasan, Ph.D. – THE HASAN LABORATORY". hasanlab.mgh.harvard.edu. Retrieved 2018-08-20.
  8. ↑ "Tayyaba Hasan, PhD - DF/HCC". www.dfhcc.harvard.edu. Retrieved 2018-08-20.
  9. 1 2 "Professor Tayyaba Hasan Receives IPA Award for Significant Advancement of Photodynamic Therapy". www.prnewswire.com. Retrieved 2018-08-20.
  10. 1 2 SPIETV (2010-08-26), Tayyaba Hasan on developments in photodynamic therapy , retrieved 2018-08-20
  11. ↑ "NCI Funded Research Portfolio - 1R01CA156177-01 Detail". fundedresearch.cancer.gov. Retrieved 2018-08-20.
  12. ↑ "NCI Funded Research Portfolio - 1UH2CA189901-01 Detail". fundedresearch.cancer.gov. Retrieved 2018-08-20.
  13. ↑ "THE HASAN LABORATORY – Photodynamic Therapy Research at Massachusetts General Hospital". hasanlab.mgh.harvard.edu. Retrieved 2018-08-20.
  14. ↑ "Project 1 | Hasan Program". sites.dartmouth.edu. Retrieved 2018-08-20.
  15. ↑ "Project 2 & 5 | Hasan Program". sites.dartmouth.edu. Retrieved 2018-08-20.
  16. ↑ "Project 3 | Hasan Program". sites.dartmouth.edu. Retrieved 2018-08-20.
  17. ↑ "Project 4 | Hasan Program". sites.dartmouth.edu. Retrieved 2018-08-20.
  18. ↑ Kostron, Herwig; Hasan, Tayyaba (2016). "Biographies". Photodynamic Medicine. Comprehensive Series in Photochemical & Photobiological Sciences. pp. P011–P024. doi:10.1039/9781782626824-FP011. ISBN   978-1-78262-451-6. ISSN   2041-9724.
  19. 1 2 "Pr Tayyaba Hasan - Polythea". Polythea (in French). Retrieved 2018-08-20.
  20. ↑ "2019 Fellows of The Optical Society of America" . Retrieved 18 September 2019.
  21. ↑ "ASP Spring 2018" (PDF). Retrieved 2018-08-22.
  22. ↑ "Tayyaba Hasan honored with SPIE Britton Chance Biomedical Award". spie.org. Retrieved 2018-08-20.
  23. ↑ "Tayyaba Hasan, PhD, IPA President, honored with 2018 SPIE Britton Chance Biomedical Award". International Photodynamic Association (IPA). Retrieved 2018-08-20.
  24. ↑ Reporter, India-West Staff. "SAASCR Honors 8 Indian American Researchers for Contributions to Cancer Research". India West. Retrieved 2018-08-20.
  25. ↑ Association, International Photodynamic. "Professor Tayyaba Hasan Receives IPA Award for Significant Advancement of Photodynamic Therapy". www.prnewswire.com. Retrieved 2022-03-06.
  26. ↑ "Professor Tayyaba Hasan Receives IPA Award for Significant Advancement of Photodynamic Therapy" . Retrieved 2018-08-22.
  27. ↑ "Harvard Medical School Directors' Award for Service to HST community" . Retrieved 2018-08-22.
  28. ↑ "2018 NPA Garnett-Powers & Associates, Inc. Mentor Award Recipient Announced - National Postdoctoral Association". www.nationalpostdoc.org. Retrieved 2018-08-20.
  29. ↑ "The Wellman Center for Photomedicine: About Us: Leadership". wellman.massgeneral.org. Retrieved 2018-08-20.
  30. ↑ "William Silen Lifetime Achievement Excellence in Mentoring Awards Recipients". The Office for Diversity Inclusion and Community Partnership at Harvard Medical School. Retrieved 2018-08-20.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.